Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
28.06.2007 Collaborative Search for Microorganisms in Mongolia
08.06.2007 On the Launch and Measures for Proper Use of the Anti-cancer Agent Avastin®
16.03.2007 The NHI Drug Reimbursement Price Listing and Launch of the Antiviral Agent "Copegus® Tablet 200 mg" for the Treatment of Chronic Hepatitis C
08.03.2007 Notice Concerning Acquisition of the Company's Own Shares through ToSTNet-2
27.02.2007 Judgments Granted in Favor of Chugai in Lawsuits Filed by Ajinomoto Co., Inc.
05.02.2007 Merck KGaA Seeks Approval for Erbitux for Colorectal Cancer in Japan
26.01.2007 Antiviral Agent Copegus Tablet 200mg Receives Approval as a Combination Therapy with Chronic Hepatitis C Treatment Drug Pegasys
30.11.2006 Anti-Cancer Agent, Herceptin® Application for Approval of Additional Indication of Operable Breast Cancer with HER2 Overexpression
21.11.2006 Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
20.11.2006 Syngenta Japan K.K. Appoints Andrew Guthrie as President
office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com
About Biotechnology Europe
